These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 34136522)

  • 1. Ketogenic Metabolic Therapy, Without Chemo or Radiation, for the Long-Term Management of
    Seyfried TN; Shivane AG; Kalamian M; Maroon JC; Mukherjee P; Zuccoli G
    Front Nutr; 2021; 8():682243. PubMed ID: 34136522
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of Glioblastoma Multiforme in a Patient Treated With Ketogenic Metabolic Therapy and Modified Standard of Care: A 24-Month Follow-Up.
    Elsakka AMA; Bary MA; Abdelzaher E; Elnaggar M; Kalamian M; Mukherjee P; Seyfried TN
    Front Nutr; 2018; 5():20. PubMed ID: 29651419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketogenic metabolic therapy in conjunction with standard treatment for glioblastoma: A case report.
    Phillips MCL; Thotathil Z; Dass PH; Ziad F; Moon BG
    Oncol Lett; 2024 May; 27(5):230. PubMed ID: 38586213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report: Resolution of malignant canine mast cell tumor using ketogenic metabolic therapy alone.
    Seyfried TN; Mukherjee P; Lee DC; Ta L; Nations L
    Front Nutr; 2023; 10():1157517. PubMed ID: 37057065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic management of glioblastoma multiforme using standard therapy together with a restricted ketogenic diet: Case Report.
    Zuccoli G; Marcello N; Pisanello A; Servadei F; Vaccaro S; Mukherjee P; Seyfried TN
    Nutr Metab (Lond); 2010 Apr; 7():33. PubMed ID: 20412570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Provocative Question: Should Ketogenic Metabolic Therapy Become the Standard of Care for Glioblastoma?
    Seyfried TN; Shelton L; Arismendi-Morillo G; Kalamian M; Elsakka A; Maroon J; Mukherjee P
    Neurochem Res; 2019 Oct; 44(10):2392-2404. PubMed ID: 31025151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IDH mutation and MGMT promoter methylation are associated with the pseudoprogression and improved prognosis of glioblastoma multiforme patients who have undergone concurrent and adjuvant temozolomide-based chemoradiotherapy.
    Li H; Li J; Cheng G; Zhang J; Li X
    Clin Neurol Neurosurg; 2016 Dec; 151():31-36. PubMed ID: 27764705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of MGMT methylation and IDH-1 mutation on long-term outcome for glioblastoma treated with chemoradiotherapy.
    Millward CP; Brodbelt AR; Haylock B; Zakaria R; Baborie A; Crooks D; Husband D; Shenoy A; Wong H; Jenkinson MD
    Acta Neurochir (Wien); 2016 Oct; 158(10):1943-53. PubMed ID: 27526690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic management of microenvironment acidity in glioblastoma.
    Seyfried TN; Arismendi-Morillo G; Zuccoli G; Lee DC; Duraj T; Elsakka AM; Maroon JC; Mukherjee P; Ta L; Shelton L; D'Agostino D; Kiebish M; Chinopoulos C
    Front Oncol; 2022; 12():968351. PubMed ID: 36059707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme.
    Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K
    J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frontal glioblastoma multiforme may be biologically distinct from non-frontal and multilobar tumors.
    Paldor I; Pearce FC; Drummond KJ; Kaye AH
    J Clin Neurosci; 2016 Dec; 34():128-132. PubMed ID: 27593971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility and Safety of a Combined Metabolic Strategy in Glioblastoma Multiforme: A Prospective Case Series.
    Phillips MCL; Leyden J; McManus EJ; Lowyim DG; Ziad F; Moon BG; Haji Mohd Yasin NAB; Tan A; Thotathil Z; Jameson MB
    J Oncol; 2022; 2022():4496734. PubMed ID: 36276276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glioblastoma: pathology, molecular mechanisms and markers.
    Aldape K; Zadeh G; Mansouri S; Reifenberger G; von Deimling A
    Acta Neuropathol; 2015 Jun; 129(6):829-48. PubMed ID: 25943888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential Role of Methylation Marker in Glioma Supporting Clinical Decisions.
    Roszkowski K; Furtak J; Zurawski B; Szylberg T; Lewandowska MA
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic benefit of combining calorie-restricted ketogenic diet and glutamine targeting in late-stage experimental glioblastoma.
    Mukherjee P; Augur ZM; Li M; Hill C; Greenwood B; Domin MA; Kondakci G; Narain NR; Kiebish MA; Bronson RT; Arismendi-Morillo G; Chinopoulos C; Seyfried TN
    Commun Biol; 2019; 2():200. PubMed ID: 31149644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical Analysis of ATRX, IDH1 and p53 in Glioblastoma and Their Correlations with Patient Survival.
    Chaurasia A; Park SH; Seo JW; Park CK
    J Korean Med Sci; 2016 Aug; 31(8):1208-14. PubMed ID: 27478330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic therapy: a new paradigm for managing malignant brain cancer.
    Seyfried TN; Flores R; Poff AM; D'Agostino DP; Mukherjee P
    Cancer Lett; 2015 Jan; 356(2 Pt A):289-300. PubMed ID: 25069036
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Meel M; Jindal A; Kumar M; Mathur K; Singh A
    Asian J Neurosurg; 2024 Mar; 19(1):14-20. PubMed ID: 38751398
    [No Abstract]   [Full Text] [Related]  

  • 19. Exploring the Feasibility and Effects of a Ketogenic Diet in Patients With CNS Malignancies: A Retrospective Case Series.
    Panhans CM; Gresham G; Amaral LJ; Hu J
    Front Neurosci; 2020; 14():390. PubMed ID: 32508561
    [No Abstract]   [Full Text] [Related]  

  • 20. IDH1
    Kim GH; Choi SY; Oh TI; Kan SY; Kang H; Lee S; Oh T; Ko HM; Lim JH
    Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31151327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.